The latent inhibition model of schizophrenia: Further validation using the atypical neuroleptic, clozapine

This publication has 56 references indexed in Scilit:

• The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia
  Behavioural Brain Research, 1995
• Newer and Older Antipsychotics
  CNS Drugs, 1994
• Serotonin receptors-where are they going?
  International Clinical Psychopharmacology, 1994
• The New Atypical Antipsychotics
  The British Journal of Psychiatry, 1994
• Positive and negative symptoms covary during clozapine treatment in schizophrenia
  Journal of Psychiatric Research, 1993
• MDL 73,147EF, a 5-HT3 antagonist, facilitates latent inhibition in the rat
  Pharmacology Biochemistry and Behavior, 1992
• The neuropsychology of schizophrenia
  Behavioral and Brain Sciences, 1991
• Specific anatomy, non-specific drugs: the present state of schizophrenia. 5th Biennial Winter Workshop on Schizophrenia
  Journal of Psychopharmacology, 1990
• Facilitation of the expression but not the acquisition of latent inhibition by haloperidol in rats
  Pharmacology Biochemistry and Behavior, 1987
• A theory of attention: Variations in the associability of stimuli with reinforcement.
  Psychological Review, 1975